课题基金 / 基金详情

Establishment of animal models for atheroscherosis and gene therapy

Establishment of animal models for atheroscherosis and gene therapy
动脉粥样硬化动物模型的建立及基因治疗
批准号:
05557049
负责人:
YAMADA Nobuhiro
金额:
$9.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

YAMADA Nobuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
在转基因小鼠或敲除小鼠中,可以转导或删除特定基因,以研究其功能及其与人类疾病的关系。近年来,已经建立了多种转基因小鼠或基因敲除小鼠,这些小鼠过度表达或缺乏特定基因,可用于研究人类疾病的病理生理,包括动脉粥样硬化、糖尿病和高脂血症。我们建立了整合大鼠apoE基因和人脂蛋白脂肪酶基因的转基因小鼠系。apoE的过度表达降低了血浆胆固醇和甘油三酯水平,并防止饮食引起的高胆固醇血症。建立了在H2 Ld启动子控制下apoE在动脉壁过表达的转基因模型。在该模型中,脂肪条纹病变的形成被明显抑制,提示apoE具有抗动脉粥样硬化作用。为了建立新的动脉粥样硬化动物模型,将过表达脂蛋白脂肪酶的转基因小鼠与LDL受体敲除小鼠杂交。在LDL受体敲除小鼠中,脂蛋白脂肪酶的过表达显著降低血浆残馀水平,并阻止动脉粥样硬化的进展。提示通过脂蛋白脂肪酶的作用减少血浆残余物是治疗家族性高胆固醇血症等动脉粥样硬化性疾病的有效途径。最后,我们尝试了基因治疗,这将是纠正代谢性疾病中发现的遗传异常的重要治疗方法,以预防动脉粥样硬化。
英文摘要
In the transgenic mouse or knockout mouse, a specific gene can be transduced or deleted to study its function and relation to human diseases. Recently, various lines of transgenic mice or knockout mice which overexpress or lack a specific gene have been established and are available to study the pathophysiology of human diseases, including atherosclerosis, diabetes mellitus, and hyperlipidemia. We have established transgenic mouse lines with an integrated rat apoE gene and human lipoprotein lipase gene. Overexpression of apoE reduced plasma cholesterol and triglycerides levels, and prevented diet induced hypercholesterolemia. Another transgenc model with overexpression of apoE under control of the H2 Ld promoter in the arterial wall was established. In this model, the formation of fatty streak lesions was markedly inhibited, suggesting that apoE has anti-atherogenic actions. To establish new animal models for atherosclerosis, transgenic mice overexpressing lipoprotein lipase were crossbred with LDL receptor knockout mice. Overexpression of lipoprotein lipase markedly reduced plasma remnant levels, and prevented the progression of atherosclerosis in LDL receptor knockout mice. The results suggest that the reduction in plasma remnants through the action of lipoprotein lipase is an effective way to treat atherosclerotic disorders such as familial hypercholesterolemia. Finally, we have tried gene therapy, which will be an important therapeutic approach to correct genetic abnormalities found in metabolic diseases, for the prevention of atherosclerosis.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
SUZU,S,他: "Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein" J.Clin.lnvest. 94. 1637-1641 (1994)
SUZU, S, et al.:“巨噬细胞集落刺激因子的蛋白聚糖形式结合低密度脂蛋白”J.Clin.Invest. 94. 1637-1641 (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
稲葉寿守 他: "Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages" J.Clin.Invest.92. 479-485 (1993)
Tosumori Inaba 等人:“巨噬细胞集落刺激因子调节人单核细胞来源的巨噬细胞中中性和酸性胆固醇酯水解酶的活性”J.Clin.Invest.92 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
SHIMANO,H,他: "Secretion-recapture process of apolipoprotein Ein hepatic uptake of chylomicron remnants in transgenic mice" J.Clin.lnvest.93. 2215-2223 (1994)
SHIMANO, H, 等人:“转基因小鼠中载脂蛋白 E 肝脏摄取乳糜微粒残余物的分泌-再捕获过程”J.Clin.lnvest.93 2215-2223 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K Yamamoto, H Shimano, M Shimada, M Kawamura, T Gotoda, K Harada, J Ohsuga, Y Yazaki, N Yamada: "Overexpression of apolipoprotein E prevents the development of diabetic hyperlipidemia in transgenic mice" Diabetes. 44. 580-585 (1995)
K Yamamoto、H Shimano、M Shimada、M Kawamura、T Gotoda、K Harada、J Ohsuga、Y Yazaki、N Yamada:“载脂蛋白 E 的过度表达可预防转基因小鼠患糖尿病性高脂血症”糖尿病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 26 条
    Global survey on clinical research supporting and promoting system, aiming Japanese clinical research improvement.
    • 批准号:
      19900005
    • 项目类别:
      Grant-in-Aid for Special Purposes
    • 资助金额:
      $5.76万
    • 财政年份:
      2007
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    Transcriptional regulation of energy metabolism in metabolic syndrome.
    • 批准号:
      18390268
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.17万
    • 财政年份:
      2006
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    Animal model for metabolic syndrome and its molecular basis.
    • 批准号:
      16390260
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2004
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    Regulation of signaling pathway, cell cycle, and cell growth in atherosclerosis
    • 批准号:
      13470221
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2001
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    国内基金
    海外基金
    苓桂术甘汤通过AMPK途径调控UCP2/LPL双终点发挥“温阳化饮”功效 治疗心衰的功效物质研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
    • 依托单位:
    靶向 LPL 调控DC 成熟改善三阴性乳腺癌免疫检查点阻断剂疗效的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2024
    • 负责人:
      黄银德
    • 依托单位:
    小胶质细胞LPL亚群调控内皮细胞脂质代谢重编程在颅脑创伤后脑微循环障碍中的作用机制
    • 批准号:
      82371390
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      陈祥荣
    • 依托单位:
    ANGPTL3/LPL通路调控脂质代谢在肝衰竭中的作用机制研究
    • 批准号:
      LQ23H030006
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      谢中阳
    • 依托单位: